News

Latest Update: November 2021 The app update was initially rolled out in early October for existing Android Dexcom G6 customers. For iOS devices, the update has recently been released in mid-November, 2021. October 2021 We are thrilled to bring you an update to the Dexcom G6 app! Designed to improve the user’s experience, this update …

Continue reading "Dexcom unveils update for Dexcom G6 App with New and Improved Features (Last Updated 23 Nov 2021)"

September 2021 Following an update to the Dexcom account creation interface from 9th of September 2021, selected new Dexcom G5 Mobile customers may need to complete an additional step when creating their Dexcom account. This update will not affect existing Dexcom G5 Mobile customers. For further information, please refer to this document. The update introduces …

Continue reading "Update Prompts Additional Step in Setting up Dexcom Account for some New Customers"

August 2021 AMSL Diabetes are excited to announce the sponsorship of the Willow Rose Foundation for Diabetes. The Willow Rose Foundation for Diabetes is a not-for-profit organisation that was born out of a passion to see all people living with diabetes thrive. By bringing together the experiences of individuals living with diabetes, they hope to …

Continue reading "AMSL Diabetes pledge support for Willow Rose Foundation for Diabetes"

August 2021 AMSL Diabetes are delighted to announce the sponsorship of Astra-Lia England who will be participating in the upcoming TV series of “Adventure All Stars”. The international “Adventure All Stars” program is created and produced by Charity TV Global, an award-winning Australian TV production company. They successfully combine entertainment with philanthropy; rewarding people for …

Continue reading "AMSL Diabetes announce sponsorship for Charity TV Global’s “Adventure All Stars” Series"

August 2021 AMSL Diabetes are thrilled to announce the sponsorship of the Type 1 Foundation. The Type 1 Foundation is a not-for-profit charity raising awareness of type 1 diabetes through education in schools, medical practices, and the wider community. It is a volunteer-based organisation that aims to empower a generation of young people living with …

Continue reading "AMSL Diabetes sponsor not-for-profit organisation; Type 1 Foundation"

August 2021 Richard Plowright, Managing Director and Owner of Australasian Medical & Scientific Limited (AMSL) and New Zealand Medical & Scientific (NZMS) has announced his retirement, after over 30 years of providing the Australasian market with access to leading edge healthcare solutions from all over the world. As of the 1st August 2021, Richard has …

Continue reading "Dexcom, Inc. acquires AMSL and NZMS"

7th April 2021 The Therapeutic Goods Administration (TGA) suspension of the ARTG entry for the Tandem Diabetes Care t:slim X2 insulin pump has officially been lifted. AMSL Diabetes and Tandem Diabetes Care have been in discussions with the TGA and have now successfully addressed their concerns for the t:slim X2 insulin pump. For more information …

Continue reading "Tandem t:slim X2 Insulin Pump Suspension Lifted"

29th March 2021 As of 29th March 2021, AMSL Diabetes has discontinued the sale of the t:slim X2 insulin pump with Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) integration. This announcement does not affect the supply of the t:slim X2 insulin pump with Basal-IQ™ technology and any subsequent versions of the pump. Existing customers will …

Continue reading "Tandem t:slim X2 Insulin Pump with Dexcom G5 Mobile Integration Supply Update"

15th January 2021 The Australian Government has updated the NDSS CGM Subsidy Initiative to include the NEW Dexcom G6 Continuous Glucose Monitoring System. As of Monday 18th of January 2021,  if you are using a Tandem t:slim X2 insulin pump and are eligible for the NDSS CGM Subsidy Initiative you can now have access to …

Continue reading "The Australian Government has updated the NDSS CGM Subsidy Initiative"